Table 2 Baseline characteristics of patients with anti-Xa levels within range compared to patients with anti-Xa levels out of the recommended range
| Â | Sub-prophylactic (A) | Within range (B) | Supra-prophylactic (C) | Â | Â | |
|---|---|---|---|---|---|---|
<0.2 IU/mL | 0.2-0.5 IU/mL | >0.5 IU/mL | p (ANOVA) | Post Hoc Tukey's method | ||
n | Â | 12 | 46 | 5 | Â | Â |
Age (years) | mean | 51.4 | 60.8 | 61.2 | 0.1071 | Â |
std | 14.3 | 13.7 | 11.6 | Â | Â | |
BMI (kg/m2) | mean | 28.8 | 27.1 | 20.8 | 0.0054 | C < A,B |
std | 6.1 | 4.0 | 5.2 | Â | Â | |
Creatinine (mg/dl) | mean | 0.9 | 0.9 | 0.9 | 0.9815 | Â |
std | 0.2 | 0.2 | 0.2 | Â | Â | |
eGFR (ml/min/1.73m2) | mean | 126.7 | 94.7 | 67.6 | 0.0009 | A > B,C |
std | 43.2 | 28.0 | 12.7 | Â | Â | |
Total body weight (kg) | mean | 90.1 | 76.5 | 58.6 | 0.0001 | C < B < A |
std | 16.4 | 12.4 | 11.1 | Â | Â | |
CrCl (ml/min) | mean | 121.3 | 93.7 | 68.2 | 0.0006 | A > B,C |
std | 27.9 | 26.8 | 13.0 | Â | Â | |
Height (m) | mean | 1.8 | 1.7 | 1.7 | 0.0109 | A > B,C |
std | 0.1 | 0.1 | 0.2 | Â | Â | |
| Â | Â | Â | Â | p (Pearson Chi-Square) | Â | |
Male | n | 11 | 31 | 2 | Â | Â |
Percent | 25.0% | 70.5% | 4.5% | 0.084 | Â | |
Diabetes | n | 4 | 23 | 3 | Â | Â |
Percent | 13.3% | 76.7% | 10.0% | 0.498 | Â | |
Current smoker | n | 2 | 18 | 0 | Â | Â |
Percent | 10.0% | 90.0% | 0.0% | 0.093 | Â | |